Ze Liang

413 total citations
12 papers, 233 citations indexed

About

Ze Liang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Ze Liang has authored 12 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Ze Liang's work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (2 papers) and Immunotherapy and Immune Responses (2 papers). Ze Liang is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (2 papers) and Immunotherapy and Immune Responses (2 papers). Ze Liang collaborates with scholars based in China, Ethiopia and Australia. Ze Liang's co-authors include Zhaoqi Gu, Zhouxian Pan, Zhen Shen, Huijuan Zhu, Yong Yao, Wuyang Shui, Man Li, Shi Chen, Hui Pan and Hong Xu and has published in prestigious journals such as Cell, Scientific Reports and Life Sciences.

In The Last Decade

Ze Liang

8 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ze Liang China 7 143 91 56 34 33 12 233
Hunter B. Rogers United States 4 61 0.4× 33 0.4× 39 0.7× 4 0.1× 18 0.5× 4 196
Jaime Portugal Portugal 11 52 0.4× 22 0.2× 18 0.3× 119 3.5× 12 0.4× 52 383
Alexandra Roi Romania 9 49 0.3× 35 0.4× 80 1.4× 2 0.1× 23 0.7× 22 287
Anna Avetisyan Armenia 8 49 0.3× 19 0.2× 27 0.5× 40 1.2× 5 0.2× 19 280
Yuki Yoshimi Japan 11 36 0.3× 20 0.2× 62 1.1× 11 0.3× 13 0.4× 30 324
Chengyi Huang China 6 58 0.4× 26 0.3× 41 0.7× 4 0.1× 13 0.4× 11 300
Hiroaki Tsukasaki Japan 6 32 0.2× 26 0.3× 76 1.4× 13 0.4× 7 0.2× 9 183
Maryam Koopaie Iran 11 44 0.3× 28 0.3× 65 1.2× 15 0.4× 14 0.4× 40 275
Chen Su China 9 48 0.3× 40 0.4× 58 1.0× 2 0.1× 31 0.9× 18 272
Zhengming Tang China 8 61 0.4× 23 0.3× 125 2.2× 3 0.1× 24 0.7× 12 328

Countries citing papers authored by Ze Liang

Since Specialization
Citations

This map shows the geographic impact of Ze Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Liang more than expected).

Fields of papers citing papers by Ze Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Liang. The network helps show where Ze Liang may publish in the future.

Co-authorship network of co-authors of Ze Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Ze Liang. A scholar is included among the top collaborators of Ze Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze Liang. Ze Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Yang, Chao, Ze Liang, Kexin Zhang, et al.. (2025). Cyclic RGD modified dextran-quercetin polymer micelles for targeted therapy of breast cancer. International Journal of Biological Macromolecules. 308(Pt 1). 142272–142272. 3 indexed citations
3.
Yan, Liming, Yucen Huang, Yixiao Liu, et al.. (2025). Structural basis for the concurrence of template recycling and RNA capping in SARS-CoV-2. Cell. 188(25). 7194–7205.e10.
4.
Liang, Ze, Linying Du, En Xia Zhang, et al.. (2021). Targeted-delivery of siRNA via a polypeptide-modified liposome for the treatment of gp96 over-expressed breast cancer. Materials Science and Engineering C. 121. 111847–111847. 28 indexed citations
5.
Chen, Na, et al.. (2021). Clinical Features and Management of Endometriosis among Patients with MRKH and Functional Uterine Remnants. Gynecologic and Obstetric Investigation. 86(6). 518–524. 9 indexed citations
6.
Liang, Ze, Juan Chen, Xin Yu, & Lan Zhu. (2021). Persistent Labial Minora Fusion in Reproductive Age Women: A Retrospective Case Series of Nine Patients and Review of Literature. Organogenesis. 17(1-2). 1–6. 1 indexed citations
7.
Wang, Wei, Ze Liang, Pengfei Ma, et al.. (2021). Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance. Bioconjugate Chemistry. 32(1). 73–81. 6 indexed citations
8.
Zhang, En Xia, Yuling Chen, Ze Liang, et al.. (2019). Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer. Life Sciences. 227. 145–152. 16 indexed citations
9.
Zhang, En Xia, Lei Shi, Xin Guo, et al.. (2019). 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Life Sciences. 238. 116938–116938. 13 indexed citations
10.
Zhang, En Xia, Ze Liang, Yinan Zhao, et al.. (2019). Liposome-based co-delivery of 7-O-geranyl-quercetin and IGF-1R siRNA for the synergistic treatment of non-small cell lung cancer. Journal of Drug Delivery Science and Technology. 54. 101316–101316. 17 indexed citations
11.
Chen, Shi, Zhouxian Pan, Zhaoqi Gu, et al.. (2017). The role of three-dimensional printed models of skull in anatomy education: a randomized controlled trail. Scientific Reports. 7(1). 575–575. 140 indexed citations
12.
Lu, Jin‐Chun, Ze Liang, & Zhong‐Sheng Han. (1997). [The relationship between female infertility and genital inflammation of Chlamydia trachomatis].. PubMed. 28(3). 297–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026